ARISE - Aggressive Reduction of Inflammation Stops Events
Status:
Unknown status
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
To assess the safety and efficacy of AGI-1067, as compared to placebo, in the treatment of
vascular inflammation and atherosclerosis by assessing the reduction in cardiovascular
events.